Chewy reported second-quarter fiscal 2026 net sales of $3.33 billion, up 7.3% from the prior year, while net income increased to $80.5 million. The pet retailer said the results led it to raise its full-year revenue and profitability outlook.
Petco reported essentially flat second-quarter fiscal 2026 sales while comparable sales increased 0.6% and net income rose to $38.7 million. The company reaffirmed its full-year outlook and announced an additional $75 million debt prepayment following the quarter.
Boehringer Ingelheim has opened its new U.S. Animal Health headquarters in Johns Creek, Georgia, expanding the company’s presence in a state where it also maintains animal health research, development and manufacturing operations.
Veterinary Intelligence Company has acquired Antelligence, bringing together veterinary market data, industry content and technology capabilities to provide animal health companies with more timely intelligence on practices, ownership, workforce trends and other market changes.
Phibro Animal Health reported fiscal 2026 net sales of $1.52 billion, up 17%, while adjusted EBITDA climbed 39% to $255 million. The company expects continued growth in fiscal 2027 while planning to consolidate its manufacturing network.
BiomEdit has acquired Folium Science’s technology platform and pipeline assets, adding a CRISPR-based precision microbiome platform and the Brazil-approved poultry feed additive BiomElix® One to its portfolio.
BiomEdit has acquired Folium Science’s technology platform and pipeline assets, adding a CRISPR-Cas precision microbiome technology and BiomElix® One, a poultry feed additive approved in Brazil. Financial terms of the transaction were not disclosed.
PetMeds reported $41 million in net sales for its fiscal 2026 first quarter, down nearly 20% from a year earlier, while its net loss narrowed substantially to $6.1 million. The online pet pharmacy also reported lower administrative and advertising expenses as it works toward sustainable profitability.
ImmuCell reported second-quarter product sales of $7.2 million, up 11.5% year over year, as demand for its calf health products continued to grow. The animal health biologics company also outlined an approximately $8 million manufacturing expansion intended to triple production capacity over the next 18 months.
Veterinary practice management software provider Vetspire has received a growth investment from Battery Ventures and will operate as a standalone company. The funding will support further development of Vetspire’s AI capabilities and platform, which is currently used by more than 800 veterinary hospitals and clinics.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.